Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer

The presence of tumor immune infiltrating cells (TILs), particularly CD8(+) T-cells, is a robust predictor of outcome in patients with colorectal cancer (CRC). We revisited TIL abundance specifically in patients with microsatellite stable (MSS) CRC without evidence of lymph node or metastatic spread...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Millen, Rosemary, Malaterre, Jordane, Cross, Ryan S., Carpinteri, Sandra, Desai, Jayesh, Tran, Ben, Darcy, Phillip, Gibbs, Peter, Sieber, Oliver, Zeps, Nikolajs, Waring, Paul, Fox, Stephen, Pereira, Lloyd, Ramsay, Robert G.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006930/
https://ncbi.nlm.nih.gov/pubmed/27622014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1149667
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados